EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 1.765
-0.070 (-3.81%)
Jan 30, 2026, 2:18 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 86.32 million as of January 29, 2026. Its market cap has decreased by -24.69% in one year.
Market Cap
86.32M
Enterprise Value
64.89M
Revenue
66.87M
Ranking
n/a
PE Ratio
12.61
Stock Price
1.77
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has increased from 48.72M to 86.32M, an increase of 77.18%. That is a compound annual growth rate of 12.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 86.32M | 30.14% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | 48.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 113.00M |
| Imugene | 110.32M |
| Proteomics International Laboratories | 106.57M |
| LTR Pharma | 106.26M |
| Arovella Therapeutics | 102.10M |
| Alterity Therapeutics | 87.00M |
| Prescient Therapeutics | 84.12M |
| Radiopharm Theranostics | 81.52M |